Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity

NCT05111067 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT05111067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05111067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity
Lead sponsor
Nova Scotia Health Authority
Phase
Observational
Overall status
Completed
Start date
December 1, 2021
Completion date
December 1, 2023
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple negative breast cancer